Literature DB >> 23158318

A novel assay to evaluate promoting effects of proteins on calcium oxalate crystal invasion through extracellular matrix based on plasminogen/plasmin activity.

Wararat Chiangjong1, Visith Thongboonkerd.   

Abstract

One of the important processes in kidney stone development is crystal invasion through extracellular matrix (ECM). Some proteins in renal tissue or urine have been thought to aggravate crystal invasion. However, this pathogenic mechanism has been previously under-investigated due to a lack of crystal invasion assay. In the present study, we have developed a novel assay for the investigations of calcium oxalate monohydrate (COM) crystal invasion. Matrix gel was loaded into an in-house migration chamber made on a glass slide to simulate the ECM environment. COM crystals were coated with the tested protein, which was then bound with plasminogen. The crystal-protein-(plasminogen) complex and urokinase plasminogen activator (uPA) were placed on-top of the matrix gel. If the tested protein had plasminogen-binding capability, the remaining plasminogen would be activated by uPA to plasmin, which caused crystal migration through the matrix gel. We then applied this novel assay to evaluate effects of some abundant kidney/urine proteins (including purified albumin, carbonic anhydrase, lysozyme and Tamm-Horsfall protein) on COM crystal invasion. The data revealed that albumin, which is the known plasminogen-binding protein, dramatically induced plasmin activity and crystal invasion, whereas other proteins had no significant effects as compared to the control. In summary, we have successfully developed a novel assay for the investigations of crystal invasion based on the plasminogen/plasmin system. This assay is applicable to examine proteins that may serve as potential aggravators of crystal invasion and thus will be very useful for further studies on kidney stone development.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23158318     DOI: 10.1016/j.talanta.2012.09.019

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  7 in total

1.  Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix.

Authors:  Supaporn Khamchun; Kanyarat Sueksakit; Sakdithep Chaiyarit; Visith Thongboonkerd
Journal:  J Biol Inorg Chem       Date:  2019-01-30       Impact factor: 3.358

2.  Stabilization of submicron calcium oxalate suspension by chondroitin sulfate C may be an efficient protection from stone formation.

Authors:  Jun-Jun Li; Jun-Fa Xue; Jian-Ming Ouyang
Journal:  Bioinorg Chem Appl       Date:  2013-12-08       Impact factor: 7.778

Review 3.  Roles for Exosome in Various Kidney Diseases and Disorders.

Authors:  Visith Thongboonkerd
Journal:  Front Pharmacol       Date:  2020-01-31       Impact factor: 5.810

4.  Roles of heat-shock protein 90 and its four domains (N, LR, M and C) in calcium oxalate stone-forming processes.

Authors:  Sunisa Yoodee; Paleerath Peerapen; Sirikanya Plumworasawat; Visith Thongboonkerd
Journal:  Cell Mol Life Sci       Date:  2022-07-28       Impact factor: 9.207

5.  Calcium oxalate crystals increased enolase-1 secretion from renal tubular cells that subsequently enhanced crystal and monocyte invasion through renal interstitium.

Authors:  Wararat Chiangjong; Visith Thongboonkerd
Journal:  Sci Rep       Date:  2016-04-05       Impact factor: 4.379

Review 6.  Proteomics of Crystal-Cell Interactions: A Model for Kidney Stone Research.

Authors:  Visith Thongboonkerd
Journal:  Cells       Date:  2019-09-12       Impact factor: 6.600

7.  Rosiglitazone Suppresses Renal Crystal Deposition by Ameliorating Tubular Injury Resulted from Oxidative Stress and Inflammatory Response via Promoting the Nrf2/HO-1 Pathway and Shifting Macrophage Polarization.

Authors:  Hongyan Lu; Xifeng Sun; Min Jia; Fa Sun; Jianguo Zhu; Xiaolong Chen; Kun Chen; Kehua Jiang
Journal:  Oxid Med Cell Longev       Date:  2021-10-14       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.